TickerFactsScreenerDevelopers

Theravance Biopharma, Inc. (TBPH) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2011: -$140.72M2012: -$6.99M2013: -$17.04M2014: $289.79M2015: $243.06M2016: $350.23M2017: $115.18M2018: -$51.59M2019: -$223.84M2020: -$303.75M2021: -$338.57M2022: $441.80M2023: $213.00M2024: $175.54M2025: $296.72M$296.72M
2011Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$296.72M+69.0%
2024$175.54M-17.6%
2023$213.00M-51.8%
2022$441.80M+230.5%
2021-$338.57M-11.5%
2020-$303.75M-35.7%
2019-$223.84M-333.9%
2018-$51.59M-144.8%
2017$115.18M-67.1%
2016$350.23M+44.1%
2015$243.06M-16.1%
2014$289.79M+1801.1%
2013-$17.04M-143.7%
2012-$6.99M+95.0%
2011-$140.72M—